Jody S. Lindell, Director at PDL BIOPHARMA, INC. (PDLI), bought 3,000 shares at $7.76 ($23K) on 2009-06-15, disclosed to the SEC on 2009-06-22.
Open-market purchase of $23k PDLI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| COO | SELL | 2021-07-06 | $1.8M | — | Filing → |
| COO | SELL | 2020-09-17 | $2.2M | — | Filing → |
| COO | SELL | 2020-01-07 | $1.1M | — | Filing → |